Back to Search Start Over

Is it useful to combine taxanes with targeted agents in mCRPC patients—have we hit the target in this phase II study with docetaxel and curcumin allowing going for a phase III study?

Authors :
Elise Nassif
Constance Michel
Constance Thibault
Stéphane Oudard
Source :
Translational Cancer Research. 5:S640-S644
Publication Year :
2016
Publisher :
AME Publishing Company, 2016.

Subjects

Subjects :
Cancer Research
Oncology
Radiology, Nuclear Medicine and imaging

Details

ISSN :
22196803 and 2218676X
Volume :
5
Database :
OpenAIRE
Journal :
Translational Cancer Research
Accession number :
edsair.doi...........bb0257e79f661ddeef3d79ff1788cb94
Full Text :
https://doi.org/10.21037/tcr.2016.10.78
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details